Moderna, Inc. (MRNA) Total assets 2017–2025
Moderna, Inc. (MRNA) total assets at each fiscal year-end, per SEC filings.
$12.3BFY2025 · since FY2017: $1.1B → $12.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12.3B | -12.8% |
| FY2024 | $14.1B | -23.2% |
| FY2023 | $18.4B | -28.7% |
| FY2022 | $25.9B | +4.8% |
| FY2021 | $24.7B | +236.2% |
| FY2020 | $7.3B | +361.6% |
| FY2019 | $1.6B | -19.0% |
| FY2018 | $2.0B | +80.9% |
| FY2017 | $1.1B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MRNA financial trends
MRNA RevenueMRNA Net incomeMRNA Net marginMRNA Gross profitMRNA Gross marginMRNA Operating incomeMRNA Operating marginMRNA Operating cash flowMRNA Free cash flowMRNA Capital expendituresMRNA Return on equityMRNA Stock buybacksMRNA Dividends paidMRNA Total liabilitiesMRNA Shareholders’ equityMRNA overview →